Awarded contract

Contract for the provision of Histopathology reporting, Urology and Breast MDT

  • Great Western Hospitals NHS Foundation Trust

F15: Voluntary ex ante transparency notice

Notice reference: 2023/S 000-019565

Published 10 July 2023, 8:54am



Section one: Contracting authority/entity

one.1) Name and addresses

Great Western Hospitals NHS Foundation Trust

Marlborough Road

Swindon

SN3 6BB

Contact

Debbie Parin

Email

Debbie.parin@nhs.net

Country

United Kingdom

NUTS code

UKK14 - Swindon

Internet address(es)

Main address

https://www.gwh.nhs.uk/

Buyer's address

https://www.gwh.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Contract for the provision of Histopathology reporting, Urology and Breast MDT

two.1.2) Main CPV code

  • 85111800 - Pathology services

two.1.3) Type of contract

Services

two.1.4) Short description

A contract for the provision of Histopathology reporting, Urology and Breast MDT

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £420,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Poundbury Cancer Institute
3 Queen Mother Square
Dorchester
DT1 3BJ

two.2.4) Description of the procurement

A direct award to Poundbury Cancer Institute (PCI) for the supply of Histopathology reporting, Urology and Breast MDT

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

Great Western Hospitals NHS Foundation Trust (GWH) intends to award a contract under Regulation 32(2)(b)(ii), to Poundbury Cancer Institute (PCI) in respect of Histopathology reporting, Urology and Breast MDT, for a period of one year, with an option to extend for a further period of one year. This to maintain continuation of service delivery while the separate contract end dates for this requirement at GWH and Salisbury NHS Foundation Trust (SFT) are aligned and the collaborative requirement is re-tendered as a BSW Procurement Alliance collaborative contract, to ensure greater efficiency when procuring services. PCI is the incumbent supplier and the new contract will ensure that the current service is maintained until the re-tender is complete, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following:

Trust Turnaround Times and Patient Care: Variations in turnaround while new systems are set up. Currently PCI routes for reporting are established and consistent. Risking this could lead to increased Turnaround and delays to the diagnosis, and in turn treatment, of patients within the Trust

Packaging and Transport: new routes of transport for slides and blocks have to be set up. This will add extra pressure to the departments' sendaways team. Packaging requirements may also vary, leading to additional costs of purchase, and increased time to carry out alternative packaging requirements.

IT and Report Transcription: The reporting of cases by PCI is an established process, and the departments secretarial staff are familiar with the process of transcribing the received reports onto the LIMS. A new provider could lead to additional reporting processes, or access may be required to additional external IT systems, increasing the workload of the secretaries.

Additional Testing Requirements: A new provider may wish to introduce new tests (such as Immunohistochemical markers) not routinely performed within the department. This will increase the cost as these may have to be outsourced or will have to be worked up and verified in house, adding to the department's workload. Currently the requirements of PCI are known to the department and requesting additional work is an established process.

Documentation: Changing provider will result in numerous document updates that will add to the department's ongoing quality work.

Accreditation: UKAS, would have to be informed of any changes in provider, and any tests that they require that are not on our schedule would have to be reported as unaccredited tests.

GWH has reviewed the factors described and considers that for the technical reasons listed, awarding PCI is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until the re-tender of the collaborative contract across the two Trusts. GWH will observe a 10 day standstill from the date of this notice before entering into a contract with Poundbury Cancer Institute (PCI).

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

9 July 2023

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

POUNDBURY CANCER CENTRE LTD

Newborough House 3 Queen Mother Square

Dorchester

DT1 3BJ

Country

United Kingdom

NUTS code
  • UKK2 - Dorset and Somerset
The contractor/concessionaire is an SME

Yes

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Initial estimated total value of the contract/lot/concession: £420,000

Total value of the contract/lot/concession: £420,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Salisbury Managed Procurement Services

Salisbury NHS Foundation Trust, Odstock Road

Salisbury

SP2 8BJ

Country

United Kingdom

Internet address

https://www.salisbury.nhs.uk/

six.4.4) Service from which information about the review procedure may be obtained

Salisbury Managed Procurement Services

Salisbury NHS Foundation Trust, Odstock Road

Salisbury

SP2 8BJ

Country

United Kingdom

Internet address

https://www.salisbury.nhs.uk/